HBIO Margin dodolan resik Harvard Bioscience, Inc.

Logo perusahaan publik Harvard Bioscience (HBIO)

Stable B2B contracts with universities and pharmaceutical giants minimize business risks for Harvard Bioscience (HBIO). Monthly sales margin dynamics serve as a confidence indicator, where the value of the metric is -13.20. Harvard Bioscience (HBIO) relies on its leadership in electrophysiology and supplies to Life Sciences. Meanwhile, moderate pricing power is constrained by budget cuts among US biotech startups.

Rentabilitas dodolan resik Harvard Bioscience Inc. (HBIO): kanggo periode 04.07.2022 - 19.11.2026

Ringkesan rincian data analitis Harvard Bioscience, Inc. (HBIO)

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:harvardbioscience.com - HBIO
Produk asil prodhuksi harvardbioscience.com

Sales margin measures the share of net profit in every dollar earned, revealing the actual efficiency of the business. By analyzing the current sales margin level, an investor assesses the resilience of the model, bypassing the delays of quarterly reports. Sharp fluctuations in this indicator often signal one-time write-offs or systemic failures. For Harvard Bioscience (HBIO), this metric is sensitive to the cyclicality of R&D budgets. A decline in profitability may reflect a reduction in government funding for universities or a disruption in component supply chains.

Analisis pesaing

Intuitive Surgical, Inc. (ISRG) - Margin resik|Margin resik Danaher Corporation (DHR)|Margin resik Becton Dickinson & Co|Rentabilitas dodolan resik STE (STERIS plc)|Rentabilitas dodolan miturut bathi resik WST (West Pharmaceutical Services Inc)|Rentabilitas resik perusahaan BAX|Masimo Corporation - Rentabilitas dodolan miturut bathi resik|Rentabilitas resik perusahaan STVN (Stevanato Group SpA)|TFX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Merit Medical Corp MMSI|NVST: Margin dodolan resik|ICUI - Margin dodolan perusahaan|XRAY (Sirona Dental Systems) - Margin dodolan resik|Margin resik LeMaitre Vascular Inc LMAT|Margin resik AtriCure Corp (ATRC)|Margin dodolan resik STAAR Surgical Corp (STAA)|Margin resik niagenbioscience.com NAGE|ZimVie Inc. - Margin resik|ANGO - Margin resik|Margin dodolan perusahaan Cerus Corp CERS|TKNO (Alpha Teknova Inc) - Rentabilitas dodolan miturut bathi resik|Monogram Technologies Inc - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik STSS|InfuSystem Holdings, Inc. (INFU) - Margin dodolan perusahaan|Margin dodolan resik UTMD|KORU Medical - Rentabilitas dodolan resik|Nyxoah S.A - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik MBOT|PDEX - Margin resik|ZTEK (Zentek) - Rentabilitas dodolan resik|ELUT (Elutia Inc) - Rentabilitas dodolan miturut bathi resik|MLSS - Margin dodolan perusahaan|Margin resik NEXGEL, Inc.|RVP (Retractable Technologies) - Rentabilitas resik perusahaan|Margin dodolan resik FEMY|Margin dodolan resik Meihua Medical Technologies (MHUA)|Margin dodolan resik POAI (Predictive Oncology)|CJMB - Rentabilitas dodolan miturut bathi resik|ATRI: Rentabilitas dodolan miturut bathi resik|NeuroMetrix, Inc. (NURO) - Rentabilitas dodolan miturut bathi resik